(S (NP (NP (DT The) (NN morphometry)) (PP (IN of) (NP (NP (DT a) (NN kidney) (NN tumor)) (VP (VBN revealed) (PP (IN by) (NP (NP (NN contrast) (HYPH -) (VBN enhanced) (VBN Computed) (NN Tomography)) (NML (-LRB- -LRB-) (NN CT) (-RRB- -RRB-) (NN imaging)))))))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN factor)) (PP (IN in) (NP (NP (JJ clinical) (NN decision)) (VP (VBG making) (S (VP (VBG surrounding) (NP (NP (DT the) (NN lesion) (POS 's)) (NN diagnosis) (CC and) (NN treatment))))))))) (. .))
(S (NP (NP (JJ Quantitative) (NN study)) (PP (IN of) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NML (NN kidney) (NN tumor)) (NN morphology)) (CC and) (NP (JJ clinical) (NNS outcomes))))))) (VP (VBZ is) (NP (NP (ADJP (JJ difficult) (PP (IN due) (PP (IN to) (NP (NNS data))))) (NN scarcity)) (CC and) (NP (NP (DT the) (JJ laborious) (NN nature)) (PP (IN of) (S (ADVP (RB manually)) (VP (VBG quantifying) (NP (NN imaging) (NNS predictors)))))))) (. .))
(S (S (NP (NP (JJ Automatic) (JJ semantic) (NN segmentation)) (PP (IN of) (NP (NP (NNS kidneys)) (CC and) (NP (NN kidney) (NNS tumors))))) (VP (VBZ is) (NP (NP (DT a) (JJ promising) (NN tool)) (PP (IN towards) (S (ADVP (RB automatically)) (VP (VBG quantifying) (NP (NP (DT a) (JJ wide) (NN array)) (PP (IN of) (NP (JJ morphometric) (NNS features)))))))))) (, ,) (CC but) (S (NP (DT no) (JJ sizeable) (JJ annotated) (NN dataset)) (VP (VBZ is) (ADVP (RB currently)) (ADJP (JJ available) (S (VP (TO to) (VP (VB train) (NP (NNS models)) (PP (IN for) (NP (DT this) (NN task))))))))) (. .))
(S (NP (PRP We)) (VP (VBP present) (NP (NP (DT the) (NN KiTS19) (NN challenge) (NN dataset)) (: :) (NP (NP (DT A) (NN collection)) (PP (IN of) (NP (NP (JJ multi-phase) (NN CT) (NN imaging)) (, ,) (NP (NN segmentation) (NNS masks)) (, ,) (CC and) (NP (JJ comprehensive) (JJ clinical) (NNS outcomes)))))) (PP (IN for) (NP (NP (CD 300) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (NN nephrectomy)) (PP (IN for) (NP (NN kidney) (NNS tumors))) (PP (IN at) (NP (NP (PRP$ our) (NN center)) (PP (IN between) (NP (CD 2010) (CC and) (CD 2018))))))))))) (. .))
(S (NP (NP (CD 210) (PRN (-LRB- -LRB-) (NP (CD 70) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (DT these) (NNS patients)))) (VP (VP (VBD were) (VP (VBN selected) (PP (IN at) (NP (NML (ADJP (JJ random) (PP (IN as) (NP (NP (DT the) (NN training) (NN set)) (PP (IN for) (NP (DT the) (CD 2019) (NNP MICCAI) (NNS KiTS)))))) (NN Kidney) (NN Tumor)) (NN Segmentation) (NN Challenge))))) (CC and) (VP (VBP have) (VP (VBN been) (VP (VBN released) (ADVP (RB publicly)))))) (. .))
(S (PP (IN With) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ clinical) (NN context)) (CC and) (NP (JJ surgical) (NNS outcomes)))))) (, ,) (NP (DT this) (NNS data)) (VP (MD can) (VP (VB serve) (PP (CONJP (RB not) (RB only)) (PP (IN for) (S (VP (VBG benchmarking) (NP (JJ semantic) (NN segmentation) (NNS models))))) (, ,) (CC but) (PP (ADVP (RB also)) (IN for) (S (VP (VBG developing) (CC and) (VBG studying) (NP (NP (NNS biomarkers)) (SBAR (WHNP (WDT which)) (S (VP (VBP make) (NP (NP (NN use)) (PP (IN of) (NP (NP (DT the) (NN imaging)) (CC and) (NP (JJ semantic) (NN segmentation) (NNS masks))))))))))))))) (. .))
